1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors

A compound of formula (I), or a pharmaceutically acceptable salt thereof:

• wherein,
• L is selected from the group consisting of —NH—, —NHCH2—, and —OCH2—;
• W is selected from the group consisting of N and CH;
• A is selected from the group consisting of cyclobutyl, cyclopentyl, cyclohexyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, dioxanyl, and piperidinyl;
• wherein A is optionally substituted with one or two R2 substituents and optionally substituted with one R3 substituent;
• R1 is selected from the group consisting of Cl and —NO2;
• R2 is selected from the group consisting of F, Cl, Br, I, —OH, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C6 alkoxyalkyl, and C2-C6 alkoxyalkoxy;
• and
• R3 is selected from the group consisting of cyclobutyl, oxetanyl, and morpholinyl.